The Osmanthus fragrans flower (OFF) is commonly used as an additive for tea in China and as a traditional medicine to treat dysentery, asthma and hepatitis. In the current study, we have acquired the aqueous extract of the dried OFF (OFFE) and determined its enriched acteoside contents. However, whether OFFE and acteoside can modulate melanogenesis and pigmentation has yet to be determined. We here provide novel data revealing that OFFE and acteoside inhibit melanogenesis induced by α-MSH in B16 melanoma cells via the MITF-tyrosinase signaling pathway. Treatment with α-MSH (1μM) enhanced melanin levels and tyrosinase activity, up-regulated the mRNA levels of MITF and tyrosinase and increased the dendritic number in B16 melanoma cells, effects all being intervened by OFFE and acteoside. Of interest, OFFE and acteoside showed no direct inhibition of tyrosinase activity as revealed by our ex vivo tyrosinase activity assay. In addition, OFFE produced a depigmenting action on UVB-induced hyperpigmentation in guinea pigs, as shown by the improved skin brightness and the decreased melanin staining. Our data have demonstrated that OFFE can alter melanogenesis via modulating the MITF-tyrosinase signaling thereby leading to its depigmenting action in the in vivo model. OFFE could be a substitute for acteoside as a promising skin-whitening agent.
The Osmanthus fragrans flower (OFF), one of the top ten traditional flowers in China is commonly used as an additive for tea in China. According to the record of an ancient Chinese materia medica work, the Compendium of Materia Medica, the OFF can be used to treat dysentery, asthma and hepatitis, probably due to its anti-oxidant and anti-inflammatory effects. Indeed, several lines of evidence have demonstrated that OFF contains abundant polyphenols and flavonoids and exhibits certain free radicalscavenging and anti-inflammatory abilities [1] [2] [3] [4] . For example, the aqueous extract of OFF has better anti-oxidant activity than black tea or green tea [5] . The oral administration of the ethanol extract of OFF can suppress ovalbumin-specific IgE production and inflammatory cell infiltration in the lung in mice [1] . To date, 5 phenolic compounds from the dried OFF have been identified and isolated, including tyrosyl acetate, (+)-phillygenin, (8E)-ligustroside, rutin and acteoside, of which the last one is the main polyphenol component and shows better anti-oxidant activities [3] .
In the skin-whitening study, melanin level is a key factor determining skin pigmentation, of which the tyrosinase activity is the rate-limiting step in melanin synthesis. It is well known that the skin color is commonly influenced by the exposure of ultraviolet rays (UVR), the latter of which leads to increases in the size of melanocytes, tyrosinase activity as well as the number of melanosomes and thereby affects melanin level and skin pigmentation [6] . During that process, oxidative stress is considered as an important factor in those skin alterations. In this regard, as the main phenylpropanoid glycoside in OFF extract (OFFE), the antioxidant acteoside has also been reported to exert an inhibitory effect on tyrosinase activity and melanin synthesis in B16 melanoma cells, thereby being a potential skin-whitening candidate agent [7] . In the current study, we acquired the aqueous extract of the dried OFF (OFFE) and determined its enriched acteoside contents. We then compared effects of OFFE and acteoside on melanogenesisrelated signaling molecules. Considering the expensive cost of acteoside, the possible skin-whitening effects of OFFE in the hyperpigmentation model induced by ultraviolet B irradiation in NPC Natural Product Communications We acquired the water extract of the dried OFF and determined its content of 45% acteoside by HPLC-UV-MSMS, as shown in Figure  1 . We then performed the MTT assay [8] to detect any possible toxic effects of OFFE on the cellular viability of B16 melanoma cells. OFFE at a dose of 0.125-0.5 mg/mL (acteoside level: 90-360μmol/L) did not produce any toxic effects on B16 cell survival (data not shown). However, at the dose of 2 mg/mL, OFFE showed significant antiproliferative effects (45.8%±0.7% of control).
It has been well suggested that α-melanocyte stimulating hormone (α-MSH) can modulate the activity of microphthalmia-associated transcription factor (MITF), thereby enhancing tyrosinase activity as well as the melanin level [9] . As shown in Figure 2 , α-MSH induced an increase in tyrosinase activity (45.1%±14.2%) and melanin contents (96.5%±27.7%) when compared with the control group, effects being prevented by the co-treatment with OFFE or acteoside ( Figure 2A ). The inhibitory effects by OFFE and acteoside on the MSH-upregulated melanin levels may be, at least in part ascribed to the facilitation of melanin release from B16 cells into medium. Indeed, the melanin levels in the culture media were increased following co-treatment with OFFE or acteoside, when compared with the MSH-treated group ( Figure 2B ). MSH-induced melanogenesis has been reported to involve its binding to the melanocortin-1 receptor, thereby activating MITF and subsequently up-regulating the expression of the melanogenic enzyme such as tyrosinase [10] . However, whether OFFE and acteoside can modulate the MITF-tyrosinase signaling remains to be determined. We therefore examined the changes of MITF and tyrosinase levels following the co-treatment of α-MSH with OFFE or acteoside. As shown in Figure 3 , both OFFE and acteoside decreased the levels of MITF and tyrosinase mRNA upregulated by MSH.
We then asked whether OFFE and acteoside can directly affect the tyrosinase activity. As shown in Figure 4 , the ex vivo mushroom tyrosinase activity assay did not reveal any inhibition of tyrosinase activity by OFFE or acteoside. In contrast, glabridin at 0.125 mg/mL showed a significant inhibitory effect on tyrosinase activity (Figure 4 ). It has been shown that melanin pigments in melanocytes can be transferred to the surrounding keratinocytes along the dendrites of melanocytes to form skin pigmentation and protect skin against UV light damage [11] , implying that more dendrites or dendrite outgrowth could be helpful in melanin transportation. As shown in Figure 5 , MSH induced a significant increase in the number of dendrites of melanocytes (6.2±0.7/cell) when compared with control group (2.8±0.8/cell) (p<0.05). This increase was blocked by co-treatment with OFFE (0.5mg/mL; 4.4±0.5/cell, p<0.05 vs MSH group) or acteoside (0.1125mg/mL; 4.0±0.4/cell, p<0.05 vs MSH group). We then used the hyperpigmentation model induced by UVB irradiation in guinea pigs to examine if OFFE can depigment the pigmented skin. Following the irradiation of UVB, the melanin
Osmanthus fragrans flower extract as a promising skin-whitening agent Natural Product Communications Vol. 13 (5) 2018 577 pigmentation of the guinea pig's skin gradually developed, as shown by the skin brightness changes (determined by the ΔL* values; Supplemental Figure 1 ). This hyperpigmentation could be time-dependently prevented by the oral daily treatment with OFFE or L-ascorbic acid for 30 days (Supplemental Figure 1) .
We further performed the direct detection of melanin particles in the guinea pigs' skin by using the Fontana-Masson staining. As shown in Figure 6 , the UVB irradiation led to significant dark staining of melanin particles occurred in the guinea pig's skin, effects being reversed by both OFFE and L-ascorbic acid. These data suggest a depigmenting effect by OFFE. We then treated animals with OFFE (30 mg/kg, i.o.) and analyzed the temporal changes of acteoside in plasma by using a LC/MS/MS assay. As shown in Supplemental Table 1 and Supplemental Figure 2 , the AUC 0-t of plasma acteoside is 113.6±22.9 µg/L*h following a single oral treatment with OFFE, with t 1/2 of 2.87±1.82 h and C max of 36.77±13.46 µg/L. Guinea pigs received daily oral treatment of OFFE (7.5 mg/kg, n=11; 15 mg/kg, n=11; 30 mg/kg, n=11) and L-ascorbic acid (300 mg/kg, n=8) for 30 days, with UVB irradiation once a day for 4 days at a dose of 800 mJ/cm 2 . Skins were harvested on day 30. Note a decrease of melanin level following the treatment with OFFE or L-ascorbic acid. Scale bar, 50 μm.
Relative to artificial synthetic chemicals, natural products have been good resources for skin-whitening cosmetic agents due to their fewer side effects. In that context, we have acquired the aqueous extract of the dried OFF containing 45% acteoside (i.e., OFFE) and observed that OFFE and acteoside can inhibit melanogenesis induced by α-MSH in B16 melanoma cells via the MITF-tyrosinase signaling pathway. Treatment with α-MSH enhanced melanin levels and tyrosinase activity, up-regulated the mRNA levels of MITF and tyrosinase and increased the dendritic number in B16 melanoma cells, effects all being intervened by OFFE and acteoside. Of interest, OFFE and acteoside showed no direct inhibition of tyrosinase activity as revealed by our ex vivo tyrosinase activity assay. In addition, OFFE produced a depigmenting action on UVBinduced hyperpigmentation in guinea pigs, as shown by the improved skin brightness and the decreased melanin staining. Our data have demonstrated that OFFE can alter melanogenesis via modulating the MITF-tyrosinase signaling thereby leading to its depigmenting action in the in vivo model. OFFE could be a substitute for acteoside as a promising skin-whitening agent.
It is well known that the level of melanin and its distribution in the skin is a crucial factor in determining the constitutive skin color [12] [13] [14] [15] [16] [17] . In the molecular pathway underlying melanin synthesis, tyrosinase has been identified as the rate-limiting enzyme in the transformation of L-tyrosine to L-3,4-dihydroxyphenylalaline (L-DOPA) in melanocytes. L-DOPA is then oxidized to Ldopaquinone, which is converted by dopachrome tautomerase and tyrosinase to 5,6-indolequinone-2-carboxylic acid and finally eumelanin. The melanin is synthesized and stored in melanosomes of melanocytes, transported to keratinocytes (KCs) via melanocytic dendrites and is distributed to the whole layers of epidermis through KC migration to darken the tissues [12] [13] [14] [16] [17] [18] . On the other hand, melanogenesis is also regulated by several other factors, such as ultraviolet radiation and α-MSH, thereby exerting an effect on skin color. In this regard, the tyrosinase activity and the melanin level are both subject to modulation by OFFE and acteoside at the cellular level following stimulation with α-MSH in our study. Interestingly, MSH-induced increase in melanocytic dendrites are decreased by both OFFE and acteoside. These data suggest that OFFE and acteoside could be promising candidates regulating skin pigmentation. In support of the presumption, treatment with OFFE can improve the skin lightening through decreasing the melanin level in a hyperpigmentation model induced by UVB irradiation.
In mammals, α-MSH has been identified as a key molecule in the process of hyperpigmentation [14, 15, [19] [20] [21] [22] . In detail, α-MSH binds to its receptor, melanocortin-1-receptor and increases cAMP levels, leading to the activation of protein kinase A (PKA) as well as the subsequent activation of microphthalmia-associated transcription factor (MITF). The activated MITF regulates the expression of melanogenic enzymes such as tyrosinase, tyrosinase-related protein-1 (TRP-1) and TRP-2, thus promoting melanogenesis and pigment darkening ultimately. In the current study, we observed that α-MSH up-regulated the MITF and tyrosinase mRNA levels, effects being reversed by co-treatment with OFFE or acteoside. Of note, different from the direct inhibitor of tyrosinase, glabridin, OFFE and acteoside did not show any inhibitory effects on mushroom tyrosinase activity by our ex vivo tyrosinase activity assay while did inhibit cellular tyrsosinase activity. These data imply that OFFE and acteoside may affect tyrosinase activity/level and melanogenesis via modulating MITF expression.
Ultraviolet radiation, especially UVB is the main stimulus for the growth and differentiation of melanocytes, which results in the production of reactive oxygen species as well as the subsequent stimulation of keratinocytes to produce α-MSH, the latter of which has been shown to promote the synthesis of eumelanin in melanocytes [13, 18, 23, 24] . In the current hyperpigmentation model, UVB irradiation darkens the skin, probably via the α-MSHrelated pathway of melanogenesis. Consistent with this hypothesis, melanin levels as shown by the Fontana-Masson staining are increased following the UVB radiation. Correspondingly, the decrease of melanin levels by OFFE may be derived, at least in part, from its modulation of the α-MSH synthesis in keratinocytes, but yet await further clarification. Considering the expensive cost, acteoside was not delivered for the animal study. However, a pharmacokinetic study of acteoside was performed using a LC/MS/MS assay following a single oral treatment with OFFE. The AUC 0-t of plasma acteoside is 113.6±22.9 µg/L*h, with t 1/2 of 2.87±1.82 h and C max of 36.77±13.46 µg/L (Supplemental Table 1 and Supplemental Figure 2 ).
In conclusion, the aqueous extract from the dried Osmanthus fragrans flower (i.e., OFFE) containing 45% acteoside can regulate melanogenesis via intervening the MITF-tyrosinase signaling, thereby improving the skin lightening. OFFE could be a promising skin-whitening candidate agent as a substitute for acteoside.
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Osmanthus fragrans flower extract: The dried flowers of Osmanthus fragrans were purchased from Yangshuo, Guangxi, China, and grinded into powder using a mill (IKA, A11 basic). OFF (500g) were extracted with water (totally 15L) at 80˚C-90˚C for 3 times, once an hour. The extract was collected and centrifuged (Sigma, 2-16P). The centrifugate was separated through the macroporous adsorption resin (D-101, Tianjin Haiguang Chemical Corporation, LTD). The 75% ethanol elution part was collected and volatilized to remove the ethanol under vacuum (BUCHI, R210 rotavapor). Finally, a total of 85g powder of OFF extract containing 45% acteoside on a dry basis was harvested, as confirmed ( Figure  1 Cell culture: The murine B16 melanoma cells were provided by Fuxiang Biotech. Co. (Shanghai, China). B16 cells were grown in DMEM culture medium (Gibco, Life Technologies, USA) supplemented with 10% fetal bovine serum (Biotech GmbH, Germany), 100 U/mL penicillin and 100 μg/mL streptomycin (Hyclone, USA) in a humidified atmosphere with 5% CO 2 at 37˚C. A 100-μL suspension of B16 cells were plated in each well of 96-well plates at a density of 2×10 4 cells/mL. After 24h, the medium was changed and cells were incubated with different concentrations of OFFE (0-0.5 mg/mL) or acteoside combined with or without 1μM α-MSH.
Cell viability: Cell viability was determined using the MTT-based colorimetric assay [8] . Cells in 96-well flat-bottom plates were exposed to OFFE for 48h at 37˚C. And then 10 μL of MTT solution (5 mg/mL in phosphate-buffered saline) was added into each well and cells were incubated for another 4h. Following the removal of medium, 100 μL of DMSO (Merck) was added to each well, and plates were placed in an orbital shaker (TS-100, Kylin-Bell Lab Instruments, Haimen, China) to fully dissolve the formazan crystals. The optical absorbance was determined at 570 nm with an ELISA reader (Varioskan Flash, Thermo Fisher Scientific., USA). Each treatment was performed in quadruplicate and experiments were repeated at least once. Cellular tyrosinase activity assay: Cells in 96-well flat-bottom plates were exposed to OFFE or acteoside with or without 1μM α-MSH for 48h at 37˚C. Following removal of the medium, cells were washed twice with 0.01M phosphate buffer (pH 7.35~7.45) containing 0.9% NaCl. Then 50 μL of 1% Triton X-100 (Sigma, USA) was added into each well and plates were placed at -80˚C for 30min. The cell lysates were pre-warmed at 37˚C for 5min, and then incubated with 10 μL 1% L-DOPA for 2h. The optical absorbance was determined at 490 nm with an ELISA reader. Each treatment was performed in quadruplicate. The tyrosinase activity in each treatment group was expressed as the percentage of the control (% of control).
Cellular melanin content assay:
A 2-mL suspension of B16 melanoma cells was seeded onto each well of 6-well plates at a density of 1×10 5 cells/mL. After the incubation with different concentrations of OFFE or acteoside combined with or without 1μM α-MSH for 48h, cells were harvested and incubated with 1N NaOH containing 10% DMSO at 80˚C for 2h. The absorbance was determined at 490 nm. Each treatment was performed in triple. The protein level of the lysate was determined to correct the absorbance. Data were expressed as the percentage of control (% of control).
Ex vivo tyrosinase activity assay: Different concentrations of OFFE and acteoside were incubated with mushroom tyrosinase (100U/mL) for 10 min at 37ºC, and then mixed with L-DOPA (1.5 mg/mL) for 15min. The absorbance was determined at 475 nm. Each treatment was performed in triple. Glabridin was used as the positive control for tyrosinase inhibition. The activation percentage of tyrosinase activity was determined using the following formula: {[(the relative optical density (rOD) of test drug)/(rOD of control)]-1}*100%.
RNA extraction and Quantification of MITF and tyrosinase mRNA: Total RNA was extracted from mouse melanoma B16 cells using the Trizol reagent (Invitrogen, USA). Thereafter, a reverse transcription-polymerase chain reaction (RT-PCR) was performed for the conversion of total RNA (3 µg) into first-strand cDNA using a PrimeScript TM RT reagent kit (TaKaRa Bio Inc, DaLian, China) according to the manufacturer's instructions. The primers for MITF (forward primer:5'-CTGCCTGAAACCTTGCTATGC-3'; reverse primer:5'-GACTCTGTGGGGAAAATACACGC-3'), tyrosinase (forward primer: 5'-CGATGGAACACCTGAGGGAC-3'; reverse primer:5'-TTCGCAGCCATTGTGTTCAAA-3') and GAPDH (forward primer: 5'-CCCTTAAGAGGGATGCTGCC-3'; reverse primer:5'-ACTGTGCCGTTGAATTTGCC-3') were designed on the basis of the complete cDNA sequences deposited in Genebank and verified using a nucleotide BLAST search of total gene specificity. The real-time qRT-PCR using 2xSYBR green qPCR Supermix was conducted on the Stratagene Mx3000P PCR machine (Agilent Technologies, USA). The cycle threshold (C T ) values for MITF and tyrosinase were normalized to GAPDH and analyzed with MxPro software. Relative expression of mRNA was defined as the ratio of the normalized value from the treatment group against that from the respective control group.
Dendrite formation assay: B16 cells (2×10
4 cells/mL) were cultured for 24h and then treated with different concentrations of OFFE and acteoside, combined with or without 1μM α-MSH. Following a 48 h incubation, cells were rinsed with 0.01M PBS and fixed with 4% paraformaldehyde. The number of dendrites of each cell was examined by microscopy (Nikon, Tokyo, Japan). A total of ~100 cells was included in each treatment.
UVB-induced hyperpigmentation in guinea pigs:
Female brownwhite guinea pigs weighing 200~300g (Shanghai Jia-gan Biological Technology Co., LTD, Shanghai, China) were used in the study. All experimental protocols were approved by the Institutional Ethics Committee and were in accordance with the guidelines of the International Association for the Study of Pain concerning the use of laboratory animals. All animals had free access to food and water and were kept in an air-conditioned room (20˚C-25˚C, 40%-70% humidity) under a 12h dark/light cycle. The dorsal brown skin of each guinea pig with an area of 4cm×4cm was shaved by using an electric razor, and exposed to UVB irradiation (SH-4B, Sigma High-Tech Co., LTD, Shanghai, China) once a day for 4 days at a dose of 800 mJ/cm 2 . The irradiation time points were days 3, 5, 7 and 9, and irradiation was delivered right after the oral administration.
The guinea pigs were divided into 5 groups, each of which included 11 animals and received different tested samples for 30 days. Group 1 was the model control receiving only water. Group 2 received 300 mg/kg/day of L-ascorbic acid. Group 3 received a dose of 30 mg/kg/day of OFFE. Group 4 was treated with OFFE at the dose of 15 mg/kg/day and group 5 received 7.5 mg/kg/day of OFFE. All tested samples were dissolved with water.
The skin brightness was determined with a reflectance spectrophotometer (NH310, 3NH Technology Co, Shenzhen, China) and expressed as the L* value. The measurement time points were 5, 10, 15, 20, 25 and 30 days following the oral administration. The L* value on day 0 was used as the control and measured right before the first administration. The pictures were also taken simultaneously on the dorsal skin on the corresponding time point. The skin brightness changes were reflected by the ∆L* values (defined as the difference between the L* value measured on each time point and that of the control).
On day 30, all animals were sacrificed after the measurement. The skin samples were collected and immersed in 10% formalin solution for 24h for morphological analysis.
Fontana-Masson's silver stain for melanin and melanocytes:
The Fontana-Masson's silver stain is specific for melanin granules and melanocytes. By using this method, skin sections (4 μm thick) were immersed in 10% silver nitrate solution at 56˚C for 30min, and then toned in 0.2% gold chloride solution. After rinsing, sections were transferred into 5% sodium thiosulfate solution for 5min, and then counterstained with hematoxylin and eosin. Sections were then dehydrated with graded alcohol, cleared in xylene and cover slipped. Staining was visualized under bright-field microscopy at 10x objective magnification (Nikon, eclipse 90i, digital sight DSu3, NIS-Elements BR 3.2). The relative grey level of a fixed area in the epidermis was determined using the Adobe Photoshop 7.0 software, which reflected the intensity of melanin staining.
